Maryam Rameshrad

Dr. Maryam Rameshrad


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2017 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
SNSomayeh Nazari
Somayeh Nazari
MRMaryam Rameshrad
Maryam Rameshrad
HHHossein Hosseinzadeh
Hossein Hosseinzadeh

25 March 2018 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
ZBZeinab Bedrood
Zeinab Bedrood
MRMaryam Rameshrad
Maryam Rameshrad
HHHossein Hosseinzadeh
Hossein Hosseinzadeh

Verified
Journal Article
Open access
PDF file
EAEftekhari Aziz
Eftekhari Aziz
SMSolmaz Maleki
Solmaz Maleki
SSSimin Sharifi
Simin Sharifi
SSSara Salatin
Sara Salatin
YSYalda Rahbar Saadat
Yalda Rahbar Saadat
Magali CucchiariniMagali Cucchiarini
Magali Cucchiarini
The repair and regeneration of articular cartilage represent important challenges for orthopedic investigators and surgeons worldwide due to its avascular, aneural structure, cellular arrangement, and dense extracellular structure. Although abundant efforts have been paid to provide tissue-engineered grafts, the use of therapeutically cell-based options for repairing cartilage remains unsolved in the clinic. Merging a clinical perspective with recent progress in nanotechnology can be helpful for developing efficient cartilage replacements. Nanomaterials, < 100 nm structural elements, can control different properties of materials by collecting them at nanometric sizes. The integration of nanomaterials holds promise in developing scaffolds that better simulate the extracellular matrix (ECM) environment of cartilage to enhance the interaction of scaffold with the cells and improve the functionality of the engineered-tissue construct. This technology not only can be used for the healing of focal defects but can also be used for extensive osteoarthritic degenerative alterations in the joint. In this review paper, we will emphasize the recent investigations of articular cartilage repair/regeneration via biomaterials. Also, the application of novel technologies and materials is discussed.

18 July 2017 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
MRMaryam Rameshrad
Maryam Rameshrad
BRBibi Marjan Razavi
Bibi Marjan Razavi
HHHossein Hosseinzadeh
Hossein Hosseinzadeh
Introduction: Saffron and its main components have traditionally been used as pharmaceutical agents. Current experimental research projects have also exhibited their applications in a wide spectrum of disorder treatments. Area covered: This review covers the demonstrated findings and patents on therapeutic/pharmaceutical properties of saffron and related derivatives, since 2000 to bold their outstanding merit on human health. An extensive literature review was performed in USP Patent, Patentscope, Espacenet and Google Patent in the field of CNS, cardiovascular, urogenital, dermatological and inflammatory disorders. Expert opinion: The growing body of patents showed the value of saffron and the respective crucial components alone or in combination with the other raw materials, herbal extracts, to apply in various therapeutic/pharmaceutical areas. They could be engaged as an adjuvant treatment in phototherapy, cancer, cardiovascular and neurodegenerative diseases and hypoxia-induced dangerous conditions. However, the application of these components in the clinic has been limited to very few drugs yet. This might be due poor clinical trials data. According the human trend toward the use of plant-derived compounds instead of medicines derived from chemical substances, special attention must be focused to link the worth of saffron, herbal medicine of third millennium, from basic sciences to patients’ bed.

1 February 2017 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MRMaryam Rameshrad
Maryam Rameshrad
BRBibi Marjan Razavi
Bibi Marjan Razavi
HHHossein Hosseinzadeh
Hossein Hosseinzadeh

1 May 2017
Verified
Journal Article
Open access
PDF file
SRSeyede Zohre Kamrani Rad
Seyede Zohre Kamrani Rad
MRMaryam Rameshrad
Maryam Rameshrad
HHHossein Hosseinzadeh
Hossein Hosseinzadeh
Berberis vulgaris and berberine, its main component, traditionally have been used for treatment of various disorders. The pharmacological properties of them have been investigated using different in vivo and in vitro models. In spite of beneficial effects of B. vulgaris on different cell lines, there are documents have revealed negative impacts of it on animal and human. In this regards, the determination of its toxicity in a scientific view is necessary. In current report, we provide classified information about the toxicity of B. vulgaris and berberine in different conditions consist of acute, sub-acute, sub-chronic and chronic state. Besides, it discusses the cytotoxicity, genotoxicity, mutagenicity, and carcinogenicity of B. vulgaris and berberine as well as developmental toxicity and clinical studies. Data from the present study indicate that their toxicity is depending on the route and duration of administration. According to present study, they could induce GI upset and ulceration, immunotoxicity, phototoxicity, neurotoxicity, cardiotoxicity and jaundice in a dose dependent manner. They should be used with caution in pregnancy, neonatal and G6PD deficiency. Besides, consideration should be taken in co-administration of berberine with drugs that are metabolized with CYP enzymes due their inhibitory effects on these enzymes. Furthermore, they evoke cytotoxicity on both normal and cancer cell line which is time and concentration dependent.